Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2002

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

paricalcitol capsule

Trial Locations (18)

11201

Long Island College Hospital, Brooklyn

14215

Erie County Medical Center, Buffalo

19140

Temple University Hospital, Philadelphia

23507

Clinical Research Associates of Tidewater, Norfolk

29425

Medical University of South Carolina, Charleston

37205

Nephrology Associates, Nashville

50309

Dialysis PC, Des Moines

55126

Twin Cities Clinical Research, Arden Hills

57105

Avera McKennan Research Institute, Sioux Falls

78219

San Antonio Kidney Disease Research Center, San Antonio

80220

Denver Nephrologists, Denver

80262

University of CO Health Sciences Center, Denver

90073

VA Greater Los Angeles Healthcare System, West Los Angeles, Los Angeles

92501

Nephrology Associates Medical Group, Riverside

93065

Kidney Center, Inc., Simi Valley

98405

FHS Research Center, Tacoma

Unknown

Wojewodzki Szpital Specjalistyczny AM w Bialymstoku, Bialymstoku

Krakow Hospital, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY